Calamos Wealth Management LLC Acquires New Stake in Waters Corporation $WAT

Calamos Wealth Management LLC bought a new stake in Waters Corporation (NYSE:WAT) during the third quarter, Holdings Channel.com reports. The fund bought 19,834 shares of the medical instruments supplier’s stock, valued at approximately $8,715,000.

Several other hedge funds have also bought and sold shares of WAT. California Public Employees Retirement System grew its position in Waters by 25.4% in the first quarter. California Public Employees Retirement System now owns 138,423 shares of the medical instruments supplier’s stock worth $41,222,000 after acquiring an additional 28,074 shares in the last quarter. Dudley & Shanley Inc. raised its position in Waters by 101.3% during the second quarter. Dudley & Shanley Inc. now owns 23,590 shares of the medical instruments supplier’s stock valued at $8,847,000 after purchasing an additional 11,870 shares in the last quarter. Ramsay Stattman Vela & Price Inc. purchased a new stake in Waters during the first quarter valued at about $942,000. Hahn Capital Management LLC bought a new stake in Waters during the first quarter worth about $1,490,000. Finally, Handelsbanken Fonder AB lifted its stake in Waters by 93.1% during the second quarter. Handelsbanken Fonder AB now owns 93,653 shares of the medical instruments supplier’s stock worth $35,124,000 after purchasing an additional 45,145 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors.

Key Waters News

Here are the key news stories impacting Waters this week:

• Positive Sentiment: Waters reported $1.77 billion in third-quarter 2026 revenue and raised its full-year guidance, signaling improved expectations for the business. Waters Corporation Reports $1.77 Billion in Third Quarter 2026 Revenue and Raises Full-Year Guidance
• Positive Sentiment: The company agreed to acquire MOBILion Systems, expanding its mass spectrometry and AI-powered proteomics capabilities. The strategic fit could broaden Waters’ technology offering, though the reported item does not quantify the deal’s financial impact. Waters Corporation Acquires MOBILion Systems
• Positive Sentiment: JPMorgan, Barclays, KeyCorp, TD Cowen, Citigroup, and RBC issued reports indicating higher price targets or strong potential appreciation, reinforcing a favorable analyst outlook. JPMorgan price target Barclays outlook KeyCorp outlook TD Cowen price target Citigroup price target RBC outlook

Waters Trading Up 1.1%

WAT traded up $4.84 on Friday, hitting $457.92. 695,768 shares of the company were exchanged, compared to its average volume of 995,254. The firm has a fifty day simple moving average of $434.72 and a two-hundred day simple moving average of $372.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.29 and a current ratio of 1.86. Waters Corporation has a 12 month low of $282.77 and a 12 month high of $482.28. The stock has a market capitalization of $44.99 billion, a PE ratio of 196.53, a price-to-earnings-growth ratio of 2.62 and a beta of 1.16.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.00 by $0.10. The firm had revenue of $1.77 billion during the quarter, compared to the consensus estimate of $1.75 billion. Waters had a return on equity of 11.27% and a net margin of 3.58%. The business’s revenue was up 120.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.40 earnings per share. Sell-side analysts expect that Waters Corporation will post 14.65 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on WAT shares. Robert W. Baird upped their price objective on Waters from $456.00 to $495.00 and gave the stock an “outperform” rating in a report on Thursday, October 8th. Deutsche Bank Aktiengesellschaft raised their price objective on Waters from $400.00 to $440.00 in a report on Thursday, October 15th. Morgan Stanley set a $430.00 price objective on Waters in a report on Wednesday, August 5th. Royal Bank Of Canada boosted their target price on Waters from $475.00 to $525.00 and gave the stock an “outperform” rating in a research report on Wednesday. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $535.00 target price on shares of Waters in a research note on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $475.48.

Waters Company Profile

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples.

The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Founded in 1958 by James L.